Çѱ¹È­ÀÌÀÚÁ¦¾à, ÀÓ¿ø ÀÎ»ç ´ÜÇà
2019/01/07 09:47 ÀÔ·Â
Æ®À§ÅÍ·Î ±â»çÀü¼Û ÆäÀ̽ººÏÀ¸·Î ±â»çÀü¼Û
16¸í ÀÓ¿ø ¹× ÀÌ»ç±Þ Àλç 7ÀÏ ¹ßÇ¥
Çѱ¹È­ÀÌÀÚÁ¦¾à, ÀÓ¿ø ÀÎ»ç ¹ßÇ¥.jpg¡ã Çѱ¹È­ÀÌÀÚÁ¦¾à ÀÓ¿øÁø Àλç 16¸í
 
Çѱ¹È­ÀÌÀÚÁ¦¾à(´ëÇ¥ÀÌ»ç »çÀå ¿Àµ¿¿í, www.pfizer.co.kr)Àº ÃÖ±Ù ÀÓ¿ø ¹× ÀÌ»ç±Þ Àλ縦 7ÀÏ ¹ßÇ¥Çß´Ù.
 
Çѱ¹È­ÀÌÀÚ À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®(Innovative Medicines Business)ÀÇ ¿°Áõ ¹× ¸é¿ªÁúȯ »ç¾÷ºÎ ÃÑ°ý(Inflammation & Immunology Lead) ±èÈñ¿¬ »ó¹«¿Í Çѱ¹È­ÀÌÀÚ ÀÇÇкΠÃÑ°ý ¹× ³»°úÁúȯ »ç¾÷ºÎÀÇ ÀÇÇкΠÃÑ°ý(Country Medical Director & Internal Medicine Medical Lead)ÀÎ °­¼º½Ä »ó¹«, ÀÛ³â 10¿ù 9ÀÏ ÀÚ·Î ¹é½Å »ç¾÷ºÎ ÃÑ°ý(Vaccine Lead)·Î ÀÓ¸íµÈ ÀÓ¼Ò¸í »ó¹«, ÀλçºÎ ÃÑ°ý (HR Lead) ÀÌÀº¹Ì »ó¹«°¡ 2019³â 1¿ù 1ÀϺηΠ°¢°¢ Àü¹«·Î Á÷ÇÔÀÌ º¯°æµÇ¾ú´Ù.
 
±èÈñÁ¤ ÀÌ»ç´Â 2018³â 12¿ù 1ÀÏÀڷΠȣ½ºÇÇÅ» »ç¾÷ºÎ ÃÑ°ý(Hospital Lead)·Î ½ÂÁø ÀÓ¸íµÇ¸ç »ó¹«·Î Á÷ÇÔÀÌ º¯°æµÇ¾ú´Ù. Áö³­ 12¿ù 1ÀÏ Èñ±ÍÁúȯ »ç¾÷ºÎ ÃÑ°ý(Rare Disease Lead)·Î ½ÂÁø ÀÓ¸íµÈ Á¶¿¬Áø ÀÌ»ç¿Í ÀÓ»ó½ÃÇèºÎ ÃÑ°ý(Global Site and Study Operations) ÇÑÀ±´ö À̻簡 2019³â 1¿ù 1ÀϺηΠ°¢°¢ »ó¹«·Î Á÷ÇÔÀÌ º¯°æµÇ¾ú´Ù.
 
ÃÖ±Ù ÀÓ¸íµÈ Çѱ¹È­ÀÌÀÚÁ¦¾àÀÇ ÀϺΠ»ç¾÷ºÎ ÃÑ°ý ÀÓ¿ø ¹× 2019³â 1¿ù 1ÀϺηΠÁ÷ÇÔÀÌ º¯°æµÈ ÀÌ»ç±Þ ÀÌ»ó ÀÓÁ÷¿ø ¸í´ÜÀº ´ÙÀ½°ú °°´Ù.
 
¡Þ Àü¹« (4)
¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ ¹× ÀÇÇкΠÃÑ°ý (Innovative Medicines Business, Country Medical Director & Internal Medicine Medical Lead) °­¼º½Ä Àü¹« ¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ¿°Áõ ¹× ¸é¿ªÁúȯ »ç¾÷ºÎ ÃÑ°ý (Innovative Medicines Business, Inflammation & Immunology Lead) ±èÈñ¿¬ Àü¹« ¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ¹é½Å »ç¾÷ºÎ ÃÑ°ý (Innovative Medicines Business, Vaccine Lead) ÀÓ¼Ò¸í Àü¹« ¡ã ÀλçºÎ ÃÑ°ý (HR BOS Lead) ÀÌÀº¹Ì Àü¹«
 
¡Þ »ó¹« (3)
¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, È£½ºÇÇÅ» »ç¾÷ºÎ ÃÑ°ý (Innovative Medicines Business, Hospital Lead) ±èÈñÁ¤ »ó¹« ¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, Èñ±ÍÁúȯ »ç¾÷ºÎ ÃÑ°ý (Innovative Medicines Business, Rare Disease Lead) Á¶¿¬Áø »ó¹« ¡ã ÀÓ»ó½ÃÇèºÎ (Global Site and Study Operations) ÃÑ°ý ÇÑÀ±´ö »ó¹«
 
¡Þ ÀÌ»ç (9)
¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ, ¿µ¾÷ÆÀ (Innovative Medicines Business, Internal Medicine, Sales) ±èâ½Ä ÀÌ»ç ¡ã ÀçÁ¤ºÎ (Finance) ¹®ÈñÁ¤ ÀÌ»ç ¡ã ÀçÁ¤ºÎ (Finance) ½ÅÇö±¹ ÀÌ»ç ¡ã À̽ºÅÂºí¸®½¬Æ® ¸Þµð½¼ »ç¾÷ºÎ¹®, ¿µ¾÷ÆÀ (Established Medicines Business, Sales) À̸íÁø ÀÌ»ç ¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ, ¸¶ÄÉÆÃÆÀ (Innovative Medicines Business, Internal Medicine, Marketing Lead) ÀÌÁöÀº ÀÌ»ç ¡ã À̽ºÅÂºí¸®½¬Æ® ¸Þµð½¼ »ç¾÷ºÎ¹®, ´ë¿ÜÇù·ÂºÎ (Established Medicines Business, Corporate Affairs & Health and Value) À念ÁÖ ÀÌ»ç ¡ã ±¸¸ÅºÎ (Global Procurement Lead) Á¤ÁöÈñ ÀÌ»ç ¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ, ÀÇÇкΠ(Innovative Medicines Business, Internal Medicine, Medical) ÃÖÈñ¿¬ ÀÌ»ç ¡ã À̳뺣ÀÌƼºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ´ë¿ÜÇù·ÂºÎ (Innovative Medicines Business, Corporate Affairs) Ç¥ÁöÇö ÀÌ»ç
[ ÃÖ¿µ¼± ±âÀÚ mdilbo@hotmail.com ]
ÃÖ¿µ¼± ±âÀÚ ±âÀÚÀÇ ´Ù¸¥ ±â»ç º¸±â
±â»çÁ¦º¸ ¹× º¸µµÀÚ·á news@medicalilbo.com
¢Æ¢Æ ÀÇ·áÀϺ¸ ¢Æ¢Æ(www.medicalilbo.com) - copyright ¨Ï ¢Æ¢Æ ÀÇ·áÀϺ¸ ¢Æ¢Æ. ¹«´ÜÀüÀç & Àç¹èÆ÷ ±ÝÁö
´ñ±Û´Þ±â
  • ¸¹À̺»±â»ç
  • È­Á¦ÀÇ ´º½º

樨毢

È­Á¦ÀÇ µ¿¿µ»ó
  • ȸ»ç¼Ò°³
  • ±¤°í¾È³»
  • Á¦ÈÞ·±¤°í¹®ÀÇ
  • ±â»çÁ¦º¸
  • Á¤±â±¸µ¶½Åû
  • °í°´¼¾ÅÍ
  • ÀúÀÛ±ÇÁ¤Ã¥
  • ȸ¿ø¾à°ü
  • °³ÀÎÁ¤º¸Ãë±Þ¹æħ
  • À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ
  • RSS
  • ÀÇ·áÀϺ¸ www.medicalilbo.com | ¼³¸³ÀÏ : 2009³â 9¿ù 7ÀÏ | ¥Ø 06653 ¼­¿ï½Ã ¼­Ãʱ¸ ¼­Ãʵ¿ 1589-14 ½Å¼º¿ÀÇǽºÅÚ Bµ¿ 407È£
    »ç¾÷ÀÚµî·Ï¹øÈ£ : 105-07-38362 | µî·Ï¹øÈ£ : ¼­¿ï½Ã ´Ù 09845
    ÀüÈ­ : 02) 333-3739, 363-3730 ±¤°í¹®ÀÇ : 02) 333-3739 | Æѽº 02) 363-3730 |  news@medicalilbo.com
    Copyright ¨Ï 2009 medicalilbo.com All right reserved.
    ¢Æ¢Æ ÀÇ·áÀϺ¸ ¢Æ¢ÆÀÇ ¸ðµç ÄÜÅÙÃ÷(±â»ç)´Â ÀúÀ۱ǹýÀÇ º¸È£¸¦ ¹Þ½À´Ï´Ù. ¹«´Ü ÀüÀç·º¹»ç·¹èÆ÷ µîÀ» ±ÝÇÕ´Ï´Ù.